Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2022 | ELCC 2022: importance of the multidisciplinary team

Paul Van Schil • 14 Mar 2022
ELCC 2022
Lung Cancer

Paul Van Schil, MD, PhD, University Hospital Antwerp (UZA), Edegem, Belgium, speaks on the ELCC congress, highlighting the importance of the multidisciplinary team in the management of patients with lung cancer. This interview took place during the virtual European Lung Cancer Congress 2022.

More from Paul Van Schil

1:43
Multimodality treatment and alternative endpoints in lung cancer at ELCC 2023
Paul Van Schil • 4 Apr 2023
2:09
Lymph node resection and staging as unmet needs in thoracic surgery
Paul Van Schil • 3 Apr 2023
2:18
Stereotactic radiotherapy vs surgery in early-stage NCSLC
Paul Van Schil • 3 Apr 2023
1:47
The development of surgery for lung cancer with the evolution of neoadjuvant/adjuvant treatment
Paul Van Schil • 14 Mar 2022

Related Videos

3:35
Lung cancer initiation: towards molecular cancer prevention
Charles Swanton • 18 Apr 2024
0:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
Clive Peedell • 18 Apr 2024
0:44
BTOG 2024: networking highlights and insights
Clive Peedell • 18 Apr 2024
0:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Thomas Newsom-Davis • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals